VivoSim Labs, Inc.
VIVS · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.01 | 0.01 |
| FCF Yield | -107.05% | -80.84% | -69.59% | -102.94% |
| EV / EBITDA | 1.64 | -1.14 | -0.74 | -0.23 |
| Quality | ||||
| ROIC | -28.14% | -27.58% | -243.54% | -53.74% |
| Gross Margin | 100.00% | 100.00% | 91.67% | 96.67% |
| Cash Conversion Ratio | 1.39 | -0.30 | 0.52 | 1.04 |
| Growth | ||||
| Revenue 3-Year CAGR | -27.54% | -31.67% | -26.99% | -58.51% |
| Free Cash Flow Growth | -93.61% | -12.99% | 32.17% | 11.00% |
| Safety | ||||
| Net Debt / EBITDA | 2.96 | -1.50 | 0.03 | 0.79 |
| Interest Coverage | -728.75 | -630.80 | -693.60 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 77.84 | 52.94 | -41,752.50 | 19,977.00 |